Table 2 Summary of the best docking interactions of the FDA-approved drug and natural compounds against the RdRp domain of DENV-3.
Compound | 2D interaction diagrams | 3D interaction diagrams | Bonds (Ångströms (Å)) | Binding energy (kcal/mol) |
---|---|---|---|---|
Empagliflozin | Carbon hydrogen bond: Gln760 (5.94 Å), Glu807 (5.46 Å), Lys756 (5.40 Å) Pi–Pi stacked: Tyr882 (4.77 Å, 4.83 Å) Pi–sulfur: Cys780 (6.28 Å) Pi–alkyl: Met809 (4.33 Å) | − 8.75267 | ||
Netarsudil | Hydrogen bond: Trp833 (5.03 Å), Asn777 (3.11 Å), Tyr882 (6.41 Å) Pi–anion: Asp808 (5 Å) Pi–sulfur: Cys780 (5.55 Å) Pi–Pi stacked: Tyr882 (4.78 Å) | − 8.56397 | ||
Cromolyn | Hydrogen bond: Met809 (4.67 Å), Gln760 (5.47 Å), Thr805 (5.57 Å), Lys756 (5.59 Å) Pi–Pi stacked: Trp833 (5.48 Å, 6.20 Å) | − 8.57158 | ||
Lumacaftor(VX_809) | Hydrogen bond: Gln760 (4.47 Å), Asp808 (4.22 Å) Pi–Pi T-shaped: Tyr882 (4.72 Å) Pi–alkyl: Ala785 (6.05 Å) | − 8.55727 | ||
ZINC13375652 | Hydrogen bond: Val785 (3.06 Å), Asp808 (3.81 Å) Pi–Pi stacked: Tyr882 (4.50 Å) Pi–sulfur: Cys780 (7.03 Å) Alkyl: Trp833 (6.58 Å), Met883 (5.48 Å), Val785 (4.72 Å), Cys780 (6.54 Å), Met809 (4.56 Å), Tyr882 (7.03 Å) | − 8.88069 | ||
ZINC85510542 | Pi–sulfur: Cys780 (5.9 Å) Pi–Pi stacked: Tyr882 (4.72 Å) Alkyl: Met809 (5.17 Å, 4.52 Å), Cys780 (5.17 Å), Tyr882 (5.54 Å, 5.7 Å), Val785 (4.82 Å, 5.41 Å, 5.23 Å), His786 (5.43 Å) | − 8.88656 | ||
ZINC85491556 | Hydrogen bond: Gln760 (5.32 Å), Met809 (3.98 Å) Pi–sulfur: Cys780 (5.14 Å) Pi–alkyl: Cys780 (5.47 Å), Met809 (4.65 Å, 6.21 Å), Thr882 (3.85 Å) Alkyl: Leu (4.24 Å), Met883 (5.69 Å) | − 8.67629 | ||
ZINC14679204 | Hydrogen bond: Asp808 (3.39 Å), Leu810 (4.82 Å) Pi–sulfur: Cys780 (5.46 Å) Pi–Pi stacked: Tyr882 (4.61 Å) Alkyl: Val785 (4.28 Å), Leu880 (6.17 Å), Met809 (4.45 Å) | − 8.71702 |